BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, with no assurance on its timing, size, or terms.
Net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Offer Details
Shares of common stock (or pre-funded warrants) to be offered through underwritten public offering.
Use of Proceeds
Intends to use net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Shelf Registration
Offering made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC.
- BioSig's proposed public offering signifies a strategic move to raise funds for specific investment purposes.
- The involvement of reputable book-running managers adds credibility to the offering process.
The announcement of the proposed public offering by BioSig Technologies Inc. reflects the company's strategic focus on raising capital for key investment initiatives.